
McMaster University researcher Lindsay Kalan (right) and MSc student Jordana Ferro examine a dish containing skin-associated bacteria.
Photo Credit: Courtesy of McMaster University
Scientific Frontline: Extended "At a Glance" Summary: The Skin Microbiome as an Antimicrobial Reservoir
The Core Concept: The human skin microbiome constitutes a vast, diverse community of bacteria, fungi, and viruses that acts as a protective barrier against external pathogens. Recent research indicates that these endogenous microbial populations naturally produce novel antimicrobial compounds to defend their host.
Key Distinction/Mechanism: Unlike traditional antibiotic discovery, which typically relies on isolating microbes from environmental soil samples, this framework investigates the human body's native flora. Certain newly discovered skin-associated bacterial species act as "fungal specialists," synthesizing previously uncharacterized chemical molecules to directly inhibit drug-resistant pathogens.
Major Frameworks/Components:
- Epithelial Isolate Collection (EPIC): A comprehensive microbial library gathered from eight distinct microenvironments on the human body, representing an estimated 95 percent of the entire human skin microbiome.
- Biosynthetic Gene Clusters: Genetic sequences responsible for producing antimicrobial chemicals. Analysis revealed that 96 percent of the identified clusters in these specific skin microbes remain uncharacterized, suggesting immense potential for novel molecular discovery.
- Fungal Specialists: Three of the newly discovered bacterial species demonstrate a highly effective ability to deter severe, drug-resistant fungal pathogens, including Candida auris and species within the Cryptococcus genus.
- Broad-Spectrum Defense: Validation experiments confirmed that these skin microbes possess chemical defenses active against over 20 human pathogens, including Escherichia coli and Staphylococcus aureus.
.jpg)
.jpg)





.jpg)

.jpg)






.jpg)

